These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4245860)

  • 1. [Effect of combined therapy with lysosome labilizer and antineoplastic agents with reference to increased effect of mitomycin C by lipoprotein lipase].
    Niitani H; Inagaki J; Taniguchi T; Shimoyama M; Konda C
    Saishin Igaku; 1970 Jan; 25(1):172-6. PubMed ID: 4245860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synergic effects of lysosome labilizer and anti-neoplastic agents with special reference to the effects of plasmin and mitomycin-C].
    Niitani H; Suzuki A; Konda C; Taniguchi T; Inagaki J
    Saishin Igaku; 1968 Oct; 23(10):2168-72. PubMed ID: 4237729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical studies on cancer chemotherapy--enhancement of the cytocidal effect of Mitomycin-C by one of lysosome labilizer, plasmin].
    Taniguchi T
    Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):290-309. PubMed ID: 4266268
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combination treatment with mitomycin-c and lysosome labilizers on nodular pulmonary metastases.
    Niitani H; Suzuki A; Taniguchi T; Saijo N; Kawase I; Kimura K
    Gan; 1974 Oct; 65(5):403-9. PubMed ID: 4279834
    [No Abstract]   [Full Text] [Related]  

  • 5. Labilizing affect of lipoprotein lipase on lysosomes of tumor cells.
    Niitani H; Taniguchi T; Inagaki J; Kimura K
    Gan; 1971 Feb; 62(1):61-3. PubMed ID: 5553382
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of lysosomes in cancer chemotherapy. 3. Influence of plasmin on the lysosomes of tumor cells and on the cytocidal effect of mitomycin-C.
    Shimoyama M; Niitani H; Taniguchi T; Inagaki J; Kimura K
    Gan; 1969 Feb; 60(1):33-9. PubMed ID: 4238525
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of lysosomes in cancer chemotherapy. II. Effect of mitomycin-C injection on lysosomal enzymic activities of Yoshida ascites sarcoma cells.
    Niitani H; Suzuki A; Shimoyama M; Kimura K
    Gan; 1966 Apr; 57(2):193-200. PubMed ID: 5959699
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on combined use of carcinostatica with special reference to the combination of cobaltiprotoporphyrin and mitomycin C].
    Konishi K
    Sapporo Igaku Zasshi; 1966; 29(1):47-62. PubMed ID: 6006285
    [No Abstract]   [Full Text] [Related]  

  • 9. [Potentiation of mitomycin C by dextran sulfate].
    Niitani H; Taniguchi T; Konda C; Suzuki A; Kimura K
    Gan No Rinsho; 1971; 17(9):700-3. PubMed ID: 5165864
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the combined treatment of radiation and carcinostatic agents on Yoshida sarcoma cells.
    Adachi T; Saito T
    Bull Tokyo Med Dent Univ; 1966 Dec; 13(4):445-66. PubMed ID: 5234383
    [No Abstract]   [Full Text] [Related]  

  • 11. [EFFECT OF MITOMYCIN-C INJECTION ON LYSOSOMAL ENZYMIC ACTIVITIES OF YOSHIDA ASCITES SARCOMA].
    NIITANI H; SUZUKI A; SHIMOYAMA M; KIMURA K
    Gan; 1964 Oct; 55():447-9. PubMed ID: 14247594
    [No Abstract]   [Full Text] [Related]  

  • 12. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
    Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the prevention of side-effects of the anti-cancer agent, mitomycin C by xylitol].
    Iwasa H; Takahashi M
    Gan No Rinsho; 1968 Jul; 14(7):561-5. PubMed ID: 5749780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Review of recent studies on the lysosome and its application for cancer therapy].
    Kimura K; Niitani H; Suzuki A; Shimoyama M
    Saishin Igaku; 1966 Oct; 21(10):2268-80. PubMed ID: 5343087
    [No Abstract]   [Full Text] [Related]  

  • 15. [The cytotoxic effect of plasmin on yoshida sarcoma cells].
    Hiemeyer V; Hilgard P; Kottmann R
    Z Krebsforsch; 1969; 72(1):36-42. PubMed ID: 4183690
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences of lysosomal membranes stabilities recognized between tumor cells and non-tumor cells against lysosome labilizers.
    Taniguchi T; Niitani H; Saijo N; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1976 Jun; 11(2):218-26. PubMed ID: 987123
    [No Abstract]   [Full Text] [Related]  

  • 17. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of lysosomes in cancer chemotherapy. I. A study of lysosomal enzymes in Yoshida ascites sarcoma cells.
    Suzuki A; Niitani H; Shimoyama M; Kimura K
    Gan; 1966 Apr; 57(2):185-92. PubMed ID: 5959698
    [No Abstract]   [Full Text] [Related]  

  • 19. Study on adjuvant therapeies in cancer chemotherapy, with special reference to the conbination of hyperthermia and hyperbaric oxygenation.
    Mori K
    Nagoya J Med Sci; 1967 Mar; 29(4):275-316. PubMed ID: 4964778
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional intravascular chemotherapy for experimental liver metastasis.
    Ichihashi H; Hisazaki M; Yasue M; Kondo T
    Nagoya J Med Sci; 1974 Mar; 36(2):63-9. PubMed ID: 4854065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.